 | • レポートコード：GIR201105155 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、メサラミンの世界市場を調査対象にし、メサラミンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（純度≥97％、純度≥98％、純度≥99％）、用途別分析（メサラジン錠、メサラジンカプセル、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Syntese A/S、Corden Pharma Bergamo、Ipca Laboratories、Divis Laboratories、Erregierre SpA、Cambrex Corporation、Ishita Active Pharma Ingredients、Lasa Loboratory、PharmaZell、CTX Lifescience、YC Biotech (Jiangsu)、Xinxiang Tianfeng Fine Chemical ・メーカー別販売量、売上、市場シェア ・メサラミンの地域別市場分析 ・メサラミンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・メサラミンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・メサラミンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・メサラミンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・メサラミンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・メサラミンの種類別市場規模2015-2020：純度≥97％、純度≥98％、純度≥99％ ・メサラミンの用途別市場規模2015-2020：メサラジン錠、メサラジンカプセル、その他 ・メサラミンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Mesalamine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 161.8 million by 2025, from USD 138.5 million in 2019.
The Mesalamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Mesalamine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Mesalamine market has been segmented into
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
By Application, Mesalamine has been segmented into:
Mesalazine Tablets
Mesalazine Capsules
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Mesalamine market presented in the report. This section sheds light on the sales growth of different regional and country-level Mesalamine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Mesalamine market.
The report offers in-depth assessment of the growth and other aspects of the Mesalamine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Mesalamine Market Share Analysis
Mesalamine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Mesalamine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Mesalamine sales, revenue and market share for each player covered in this report.
The major players covered in Mesalamine are:
Syntese A/S
Corden Pharma Bergamo
Ipca Laboratories
Divis Laboratories
Erregierre SpA
Cambrex Corporation
Ishita Active Pharma Ingredients
Lasa Loboratory
PharmaZell
CTX Lifescience
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Among other players domestic and global, Mesalamine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mesalamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mesalamine, with price, sales, revenue and global market share of Mesalamine in 2018 and 2019.
Chapter 3, the Mesalamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mesalamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Mesalamine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Mesalamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Mesalamine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mesalamine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Purity ≥ 97 %
1.2.3 Purity ≥ 98 %
1.2.4 Purity ≥ 99 %
1.3 Market Analysis by Application
1.3.1 Overview: Global Mesalamine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Overview of Global Mesalamine Market
1.4.1 Global Mesalamine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Syntese A/S
2.1.1 Syntese A/S Details
2.1.2 Syntese A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Syntese A/S SWOT Analysis
2.1.4 Syntese A/S Product and Services
2.1.5 Syntese A/S Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Corden Pharma Bergamo
2.2.1 Corden Pharma Bergamo Details
2.2.2 Corden Pharma Bergamo Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Corden Pharma Bergamo SWOT Analysis
2.2.4 Corden Pharma Bergamo Product and Services
2.2.5 Corden Pharma Bergamo Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ipca Laboratories
2.3.1 Ipca Laboratories Details
2.3.2 Ipca Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ipca Laboratories SWOT Analysis
2.3.4 Ipca Laboratories Product and Services
2.3.5 Ipca Laboratories Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Divis Laboratories
2.4.1 Divis Laboratories Details
2.4.2 Divis Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Divis Laboratories SWOT Analysis
2.4.4 Divis Laboratories Product and Services
2.4.5 Divis Laboratories Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Erregierre SpA
2.5.1 Erregierre SpA Details
2.5.2 Erregierre SpA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Erregierre SpA SWOT Analysis
2.5.4 Erregierre SpA Product and Services
2.5.5 Erregierre SpA Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cambrex Corporation
2.6.1 Cambrex Corporation Details
2.6.2 Cambrex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cambrex Corporation SWOT Analysis
2.6.4 Cambrex Corporation Product and Services
2.6.5 Cambrex Corporation Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ishita Active Pharma Ingredients
2.7.1 Ishita Active Pharma Ingredients Details
2.7.2 Ishita Active Pharma Ingredients Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ishita Active Pharma Ingredients SWOT Analysis
2.7.4 Ishita Active Pharma Ingredients Product and Services
2.7.5 Ishita Active Pharma Ingredients Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lasa Loboratory
2.8.1 Lasa Loboratory Details
2.8.2 Lasa Loboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lasa Loboratory SWOT Analysis
2.8.4 Lasa Loboratory Product and Services
2.8.5 Lasa Loboratory Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 PharmaZell
2.9.1 PharmaZell Details
2.9.2 PharmaZell Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 PharmaZell SWOT Analysis
2.9.4 PharmaZell Product and Services
2.9.5 PharmaZell Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 CTX Lifescience
2.10.1 CTX Lifescience Details
2.10.2 CTX Lifescience Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 CTX Lifescience SWOT Analysis
2.10.4 CTX Lifescience Product and Services
2.10.5 CTX Lifescience Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 YC Biotech (Jiangsu)
2.11.1 YC Biotech (Jiangsu) Details
2.11.2 YC Biotech (Jiangsu) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 YC Biotech (Jiangsu) SWOT Analysis
2.11.4 YC Biotech (Jiangsu) Product and Services
2.11.5 YC Biotech (Jiangsu) Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Xinxiang Tianfeng Fine Chemical
2.12.1 Xinxiang Tianfeng Fine Chemical Details
2.12.2 Xinxiang Tianfeng Fine Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Xinxiang Tianfeng Fine Chemical SWOT Analysis
2.12.4 Xinxiang Tianfeng Fine Chemical Product and Services
2.12.5 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Mesalamine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Mesalamine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Mesalamine Manufacturer Market Share in 2019
3.3.2 Top 6 Mesalamine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Mesalamine Sales, Revenue and Market Share by Regions
4.1.1 Global Mesalamine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Mesalamine Revenue and Market Share by Regions (2015-2020)
4.2 North America Mesalamine Sales and Growth Rate (2015-2020)
4.3 Europe Mesalamine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Mesalamine Sales and Growth Rate (2015-2020)
4.5 South America Mesalamine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Mesalamine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Mesalamine Sales, Revenue and Market Share by Country
5.1.1 North America Mesalamine Sales and Market Share by Country (2015-2020)
5.1.2 North America Mesalamine Revenue and Market Share by Country (2015-2020)
5.2 United States Mesalamine Sales and Growth Rate (2015-2020)
5.3 Canada Mesalamine Sales and Growth Rate (2015-2020)
5.4 Mexico Mesalamine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Mesalamine Sales, Revenue and Market Share by Country
6.1.1 Europe Mesalamine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Mesalamine Revenue and Market Share by Country (2015-2020)
6.2 Germany Mesalamine Sales and Growth Rate (2015-2020)
6.3 UK Mesalamine Sales and Growth Rate (2015-2020)
6.4 France Mesalamine Sales and Growth Rate (2015-2020)
6.5 Russia Mesalamine Sales and Growth Rate (2015-2020)
6.6 Italy Mesalamine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Mesalamine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Mesalamine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Mesalamine Revenue and Market Share by Regions (2015-2020)
7.2 China Mesalamine Sales and Growth Rate (2015-2020)
7.3 Japan Mesalamine Sales and Growth Rate (2015-2020)
7.4 Korea Mesalamine Sales and Growth Rate (2015-2020)
7.5 India Mesalamine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Mesalamine Sales and Growth Rate (2015-2020)
7.7 Australia Mesalamine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Mesalamine Sales, Revenue and Market Share by Country
8.1.1 South America Mesalamine Sales and Market Share by Country (2015-2020)
8.1.2 South America Mesalamine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Mesalamine Sales and Growth Rate (2015-2020)
8.3 Argentina Mesalamine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Mesalamine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Mesalamine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Mesalamine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Mesalamine Sales and Growth Rate (2015-2020)
9.3 Turkey Mesalamine Sales and Growth Rate (2015-2020)
9.4 Egypt Mesalamine Sales and Growth Rate (2015-2020)
9.5 South Africa Mesalamine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Mesalamine Sales and Market Share by Type (2015-2020)
10.2 Global Mesalamine Revenue and Market Share by Type (2015-2020)
10.3 Global Mesalamine Price by Type (2015-2020)
11 Global Mesalamine Market Segment by Application
11.1 Global Mesalamine Sales Market Share by Application (2015-2020)
11.2 Global Mesalamine Revenue Market Share by Application (2015-2020)
11.3 Global Mesalamine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Mesalamine Sales, Revenue and Growth Rate (2021-2025)
12.2 Mesalamine Market Forecast by Regions (2021-2025)
12.2.1 North America Mesalamine Market Forecast (2021-2025)
12.2.2 Europe Mesalamine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Mesalamine Market Forecast (2021-2025)
12.2.4 South America Mesalamine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Mesalamine Market Forecast (2021-2025)
12.3 Mesalamine Market Forecast by Type (2021-2025)
12.3.1 Global Mesalamine Sales Forecast by Type (2021-2025)
12.3.2 Global Mesalamine Market Share Forecast by Type (2021-2025)
12.4 Mesalamine Market Forecast by Application (2021-2025)
12.4.1 Global Mesalamine Sales Forecast by Application (2021-2025)
12.4.2 Global Mesalamine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Mesalamine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Mesalamine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Syntese A/S Basic Information, Manufacturing Base and Competitors
Table 8. Syntese A/S Mesalamine Major Business
Table 9. Syntese A/S Mesalamine Total Revenue (USD Million) (2018-2019)
Table 10. Syntese A/S SWOT Analysis
Table 11. Syntese A/S Mesalamine Product and Services
Table 12. Syntese A/S Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Corden Pharma Bergamo Basic Information, Manufacturing Base and Competitors
Table 14. Corden Pharma Bergamo Mesalamine Major Business
Table 15. Corden Pharma Bergamo Mesalamine Total Revenue (USD Million) (2018-2019)
Table 16. Corden Pharma Bergamo SWOT Analysis
Table 17. Corden Pharma Bergamo Mesalamine Product and Services
Table 18. Corden Pharma Bergamo Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Ipca Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Ipca Laboratories Mesalamine Major Business
Table 21. Ipca Laboratories Mesalamine Total Revenue (USD Million) (2018-2019)
Table 22. Ipca Laboratories SWOT Analysis
Table 23. Ipca Laboratories Mesalamine Product and Services
Table 24. Ipca Laboratories Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Divis Laboratories Basic Information, Manufacturing Base and Competitors
Table 26. Divis Laboratories Mesalamine Major Business
Table 27. Divis Laboratories Mesalamine Total Revenue (USD Million) (2018-2019)
Table 28. Divis Laboratories SWOT Analysis
Table 29. Divis Laboratories Mesalamine Product and Services
Table 30. Divis Laboratories Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Erregierre SpA Basic Information, Manufacturing Base and Competitors
Table 32. Erregierre SpA Mesalamine Major Business
Table 33. Erregierre SpA Mesalamine Total Revenue (USD Million) (2018-2019)
Table 34. Erregierre SpA SWOT Analysis
Table 35. Erregierre SpA Mesalamine Product and Services
Table 36. Erregierre SpA Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Cambrex Corporation Basic Information, Manufacturing Base and Competitors
Table 38. Cambrex Corporation Mesalamine Major Business
Table 39. Cambrex Corporation Mesalamine Total Revenue (USD Million) (2018-2019)
Table 40. Cambrex Corporation SWOT Analysis
Table 41. Cambrex Corporation Mesalamine Product and Services
Table 42. Cambrex Corporation Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Ishita Active Pharma Ingredients Basic Information, Manufacturing Base and Competitors
Table 44. Ishita Active Pharma Ingredients Mesalamine Major Business
Table 45. Ishita Active Pharma Ingredients Mesalamine Total Revenue (USD Million) (2018-2019)
Table 46. Ishita Active Pharma Ingredients SWOT Analysis
Table 47. Ishita Active Pharma Ingredients Mesalamine Product and Services
Table 48. Ishita Active Pharma Ingredients Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Lasa Loboratory Basic Information, Manufacturing Base and Competitors
Table 50. Lasa Loboratory Mesalamine Major Business
Table 51. Lasa Loboratory Mesalamine Total Revenue (USD Million) (2018-2019)
Table 52. Lasa Loboratory SWOT Analysis
Table 53. Lasa Loboratory Mesalamine Product and Services
Table 54. Lasa Loboratory Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. PharmaZell Basic Information, Manufacturing Base and Competitors
Table 56. PharmaZell Mesalamine Major Business
Table 57. PharmaZell Mesalamine Total Revenue (USD Million) (2018-2019)
Table 58. PharmaZell SWOT Analysis
Table 59. PharmaZell Mesalamine Product and Services
Table 60. PharmaZell Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. CTX Lifescience Basic Information, Manufacturing Base and Competitors
Table 62. CTX Lifescience Mesalamine Major Business
Table 63. CTX Lifescience Mesalamine Total Revenue (USD Million) (2018-2019)
Table 64. CTX Lifescience SWOT Analysis
Table 65. CTX Lifescience Mesalamine Product and Services
Table 66. CTX Lifescience Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. YC Biotech (Jiangsu) Basic Information, Manufacturing Base and Competitors
Table 68. YC Biotech (Jiangsu) Mesalamine Major Business
Table 69. YC Biotech (Jiangsu) Mesalamine Total Revenue (USD Million) (2018-2019)
Table 70. YC Biotech (Jiangsu) SWOT Analysis
Table 71. YC Biotech (Jiangsu) Mesalamine Product and Services
Table 72. YC Biotech (Jiangsu) Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Xinxiang Tianfeng Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 74. Xinxiang Tianfeng Fine Chemical Mesalamine Major Business
Table 75. Xinxiang Tianfeng Fine Chemical Mesalamine Total Revenue (USD Million) (2018-2019)
Table 76. Xinxiang Tianfeng Fine Chemical SWOT Analysis
Table 77. Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services
Table 78. Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Mesalamine Sales by Manufacturer (2018-2019) (Ton)
Table 80. Global Mesalamine Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Mesalamine Sales by Regions (2015-2020) (Ton)
Table 82. Global Mesalamine Sales Market Share by Regions (2015-2020)
Table 83. Global Mesalamine Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Mesalamine Sales by Countries (2015-2020) (Ton)
Table 85. North America Mesalamine Sales Market Share by Countries (2015-2020)
Table 86. North America Mesalamine Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Mesalamine Revenue Market Share by Countries (2015-2020)
Table 88. Europe Mesalamine Sales by Countries (2015-2020) (Ton)
Table 89. Europe Mesalamine Sales Market Share by Countries (2015-2020)
Table 90. Europe Mesalamine Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Mesalamine Sales by Regions (2015-2020) (Ton)
Table 92. Asia-Pacific Mesalamine Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Mesalamine Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Mesalamine Sales by Countries (2015-2020) (Ton)
Table 95. South America Mesalamine Sales Market Share by Countries (2015-2020)
Table 96. South America Mesalamine Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Mesalamine Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Mesalamine Sales by Countries (2015-2020) (Ton)
Table 99. Middle East & Africa Mesalamine Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Mesalamine Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Mesalamine Revenue Market Share by Countries (2015-2020)
Table 102. Global Mesalamine Sales by Type (2015-2020) (Ton)
Table 103. Global Mesalamine Sales Share by Type (2015-2020)
Table 104. Global Mesalamine Revenue by Type (2015-2020) (USD Million)
Table 105. Global Mesalamine Revenue Share by Type (2015-2020)
Table 106. Global Mesalamine Sales by Application (2015-2020) (Ton)
Table 107. Global Mesalamine Sales Share by Application (2015-2020)
Table 108. Global Mesalamine Sales Forecast by Regions (2021-2025) (Ton)
Table 109. Global Mesalamine Market Share Forecast by Regions (2021-2025)
Table 110. Global Mesalamine Sales Forecast by Type (2021-2025) (Ton)
Table 111. Global Mesalamine Market Share Forecast by Type (2021-2025)
Table 112. Global Mesalamine Sales Forecast by Application (2021-2025)
Table 113. Global Mesalamine Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Mesalamine Picture
Figure 2. Global Sales Market Share of Mesalamine by Type in 2019
Figure 3. Purity ≥ 97 % Picture
Figure 4. Purity ≥ 98 % Picture
Figure 5. Purity ≥ 99 % Picture
Figure 6. Mesalamine Sales Market Share by Application in 2018
Figure 7. Mesalazine Tablets Picture
Figure 8. Mesalazine Capsules Picture
Figure 9. Others Picture
Figure 10. Global Mesalamine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Mesalamine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Mesalamine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Mesalamine Sales Market Share by Manufacturer in 2019
Figure 31. Global Mesalamine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Mesalamine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Mesalamine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 36. Global Mesalamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Mesalamine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Mesalamine Revenue Market Share by Regions in 2018
Figure 39. North America Mesalamine Sales and Growth Rate (2015-2020)
Figure 40. Europe Mesalamine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Mesalamine Sales and Growth Rate (2015-2020)
Figure 42. South America Mesalamine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Mesalamine Sales and Growth Rate (2015-2020)
Figure 44. North America Mesalamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Mesalamine Sales Market Share by Countries (2015-2020)
Figure 46. North America Mesalamine Sales Market Share by Countries in 2018
Figure 47. North America Mesalamine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Mesalamine Revenue Market Share by Countries in 2018
Figure 49. United States Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 50. Canada Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 51. Mexico Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 52. Europe Mesalamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Mesalamine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Mesalamine Revenue Market Share by Countries in 2019
Figure 55. Germany Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 56. UK Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 57. France Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 58. Russia Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 59. Italy Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 60. Asia-Pacific Mesalamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Mesalamine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Mesalamine Revenue Market Share by Regions 2019
Figure 63. China Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 64. Japan Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 65. Korea Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 66. India Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 67. Southeast Asia Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 68. South America Mesalamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Mesalamine Sales Market Share by Countries in 2019
Figure 70. South America Mesalamine Revenue Market Share by Countries in 2019
Figure 71. Brazil Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 72. Argentina Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 73. Middle East and Africa Mesalamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Mesalamine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Mesalamine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Mesalamine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 78. Egypt Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 79. Turkey Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 80. South Africa Mesalamine Sales and Growth Rate (2015-2020) (Ton)
Figure 81. Global Mesalamine Sales and Growth Rate (2021-2025) (Ton)
Figure 82. Global Mesalamine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Mesalamine Market Forecast (2021-2025) (Ton)
Figure 84. Europe Sales Mesalamine Market Forecast (2021-2025) (Ton)
Figure 85. Asia-Pacific Sales Mesalamine Market Forecast (2021-2025) (Ton)
Figure 86. South America Sales Mesalamine Market Forecast (2021-2025) (Ton)
Figure 87. Middle East & Africa Sales Mesalamine Market Forecast (2021-2025) (Ton)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
高純度水素の世界市場 2020年 Market Overview The High Purity Hydrogen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 高純度イソプロピルアルコール（IPA）の世界市場 2020年 Market Overview The High-purity Isopropyl Alcohol (IPA) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 高純度電子用酢酸の世界市場 2020年 Market Overview The High Purity Electronic Grade Acetic Acid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 高純度一酸化炭素の世界市場 2020年 Market Overview The High Purity Carbon Monoxide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 高純度パラジクロロベンゼン（PDCB）の世界市場 2020年 Market Overview The High-purity para-Dichlorobenzene (PDCB) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…